▶ 調査レポート

ニコチン禁煙のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Nicotine Cessation Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ニコチン禁煙のグローバル市場インサイト・予測(~2028年) / Global Nicotine Cessation Market Insights, Forecast to 2028 / QY2207E09260資料のイメージです。• レポートコード:QY2207E09260
• 出版社/出版日:QYResearch / 2022年7月
• レポート形態:英文、PDF、129ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のニコチン禁煙の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にニコチン禁煙の世界市場のxxx%を占める「チューインガム」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のニコチン禁煙の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのニコチン禁煙市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのニコチン禁煙市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ニコチン禁煙のグローバル主要メーカーには、GSK、Dr. Reddy's Laboratories、Cipla、Cigna、Chrono Therapeutics、Pfizer、Takeda、Achieve Life Sciences、McNeil AB、Ethismos、NJOY、Johnson & Johnson、JUUL Labs、Philip Morris International、VMR Products、Nicotek、Lorillard、Victory Electronic Cigarettes Corporation、Revolymer、Novartis International AG、Imperial Brands Plcなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ニコチン禁煙市場は、種類と用途によって区分されます。世界のニコチン禁煙市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
チューインガム、パッチ、スプレー&吸入器、その他

【用途別セグメント】
病院、診療所、薬局、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ニコチン禁煙製品概要
- 種類別市場(チューインガム、パッチ、スプレー&吸入器、その他)
- 用途別市場(病院、診療所、薬局、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のニコチン禁煙販売量予測2017-2028
- 世界のニコチン禁煙売上予測2017-2028
- ニコチン禁煙の地域別販売量
- ニコチン禁煙の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ニコチン禁煙販売量
- 主要メーカー別ニコチン禁煙売上
- 主要メーカー別ニコチン禁煙価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(チューインガム、パッチ、スプレー&吸入器、その他)
- ニコチン禁煙の種類別販売量
- ニコチン禁煙の種類別売上
- ニコチン禁煙の種類別価格
・用途別市場規模(病院、診療所、薬局、その他)
- ニコチン禁煙の用途別販売量
- ニコチン禁煙の用途別売上
- ニコチン禁煙の用途別価格
・北米市場
- 北米のニコチン禁煙市場規模(種類別、用途別)
- 主要国別のニコチン禁煙市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのニコチン禁煙市場規模(種類別、用途別)
- 主要国別のニコチン禁煙市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のニコチン禁煙市場規模(種類別、用途別)
- 主要国別のニコチン禁煙市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のニコチン禁煙市場規模(種類別、用途別)
- 主要国別のニコチン禁煙市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのニコチン禁煙市場規模(種類別、用途別)
- 主要国別のニコチン禁煙市場規模(トルコ、サウジアラビア)
・企業情報
GSK、Dr. Reddy's Laboratories、Cipla、Cigna、Chrono Therapeutics、Pfizer、Takeda、Achieve Life Sciences、McNeil AB、Ethismos、NJOY、Johnson & Johnson、JUUL Labs、Philip Morris International、VMR Products、Nicotek、Lorillard、Victory Electronic Cigarettes Corporation、Revolymer、Novartis International AG、Imperial Brands Plc
・産業チェーン及び販売チャネル分析
- ニコチン禁煙の産業チェーン分析
- ニコチン禁煙の原材料
- ニコチン禁煙の生産プロセス
- ニコチン禁煙の販売及びマーケティング
- ニコチン禁煙の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ニコチン禁煙の産業動向
- ニコチン禁煙のマーケットドライバー
- ニコチン禁煙の課題
- ニコチン禁煙の阻害要因
・主な調査結果

Market Analysis and Insights: Global Nicotine Cessation Market
The global Nicotine Cessation market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Chewing Gum accounting for % of the Nicotine Cessation global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Nicotine Cessation market size is valued at US$ million in 2021, while the North America and Europe Nicotine Cessation are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nicotine Cessation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nicotine Cessation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nicotine Cessation market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nicotine Cessation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nicotine Cessation market.
Global Nicotine Cessation Scope and Market Size
Nicotine Cessation market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nicotine Cessation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Chewing Gum
Patches
Sprays and Inhalers
Others
Segment by Application
Hospital
Clinic
Pharmacy
Others
By Company
GSK
Dr. Reddy’s Laboratories
Cipla
Cigna
Chrono Therapeutics
Pfizer
Takeda
Achieve Life Sciences
McNeil AB
Ethismos
NJOY
Johnson & Johnson
JUUL Labs
Philip Morris International
VMR Products
Nicotek
Lorillard
Victory Electronic Cigarettes Corporation
Revolymer
Novartis International AG
Imperial Brands Plc
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nicotine Cessation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chewing Gum
1.2.3 Patches
1.2.4 Sprays and Inhalers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nicotine Cessation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nicotine Cessation Market Perspective (2017-2028)
2.2 Nicotine Cessation Growth Trends by Region
2.2.1 Nicotine Cessation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nicotine Cessation Historic Market Size by Region (2017-2022)
2.2.3 Nicotine Cessation Forecasted Market Size by Region (2023-2028)
2.3 Nicotine Cessation Market Dynamics
2.3.1 Nicotine Cessation Industry Trends
2.3.2 Nicotine Cessation Market Drivers
2.3.3 Nicotine Cessation Market Challenges
2.3.4 Nicotine Cessation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nicotine Cessation Players by Revenue
3.1.1 Global Top Nicotine Cessation Players by Revenue (2017-2022)
3.1.2 Global Nicotine Cessation Revenue Market Share by Players (2017-2022)
3.2 Global Nicotine Cessation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nicotine Cessation Revenue
3.4 Global Nicotine Cessation Market Concentration Ratio
3.4.1 Global Nicotine Cessation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nicotine Cessation Revenue in 2021
3.5 Nicotine Cessation Key Players Head office and Area Served
3.6 Key Players Nicotine Cessation Product Solution and Service
3.7 Date of Enter into Nicotine Cessation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nicotine Cessation Breakdown Data by Type
4.1 Global Nicotine Cessation Historic Market Size by Type (2017-2022)
4.2 Global Nicotine Cessation Forecasted Market Size by Type (2023-2028)
5 Nicotine Cessation Breakdown Data by Application
5.1 Global Nicotine Cessation Historic Market Size by Application (2017-2022)
5.2 Global Nicotine Cessation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nicotine Cessation Market Size (2017-2028)
6.2 North America Nicotine Cessation Market Size by Type
6.2.1 North America Nicotine Cessation Market Size by Type (2017-2022)
6.2.2 North America Nicotine Cessation Market Size by Type (2023-2028)
6.2.3 North America Nicotine Cessation Market Share by Type (2017-2028)
6.3 North America Nicotine Cessation Market Size by Application
6.3.1 North America Nicotine Cessation Market Size by Application (2017-2022)
6.3.2 North America Nicotine Cessation Market Size by Application (2023-2028)
6.3.3 North America Nicotine Cessation Market Share by Application (2017-2028)
6.4 North America Nicotine Cessation Market Size by Country
6.4.1 North America Nicotine Cessation Market Size by Country (2017-2022)
6.4.2 North America Nicotine Cessation Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nicotine Cessation Market Size (2017-2028)
7.2 Europe Nicotine Cessation Market Size by Type
7.2.1 Europe Nicotine Cessation Market Size by Type (2017-2022)
7.2.2 Europe Nicotine Cessation Market Size by Type (2023-2028)
7.2.3 Europe Nicotine Cessation Market Share by Type (2017-2028)
7.3 Europe Nicotine Cessation Market Size by Application
7.3.1 Europe Nicotine Cessation Market Size by Application (2017-2022)
7.3.2 Europe Nicotine Cessation Market Size by Application (2023-2028)
7.3.3 Europe Nicotine Cessation Market Share by Application (2017-2028)
7.4 Europe Nicotine Cessation Market Size by Country
7.4.1 Europe Nicotine Cessation Market Size by Country (2017-2022)
7.4.2 Europe Nicotine Cessation Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nicotine Cessation Market Size (2017-2028)
8.2 Asia-Pacific Nicotine Cessation Market Size by Type
8.2.1 Asia-Pacific Nicotine Cessation Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nicotine Cessation Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nicotine Cessation Market Share by Type (2017-2028)
8.3 Asia-Pacific Nicotine Cessation Market Size by Application
8.3.1 Asia-Pacific Nicotine Cessation Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nicotine Cessation Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nicotine Cessation Market Share by Application (2017-2028)
8.4 Asia-Pacific Nicotine Cessation Market Size by Region
8.4.1 Asia-Pacific Nicotine Cessation Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nicotine Cessation Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nicotine Cessation Market Size (2017-2028)
9.2 Latin America Nicotine Cessation Market Size by Type
9.2.1 Latin America Nicotine Cessation Market Size by Type (2017-2022)
9.2.2 Latin America Nicotine Cessation Market Size by Type (2023-2028)
9.2.3 Latin America Nicotine Cessation Market Share by Type (2017-2028)
9.3 Latin America Nicotine Cessation Market Size by Application
9.3.1 Latin America Nicotine Cessation Market Size by Application (2017-2022)
9.3.2 Latin America Nicotine Cessation Market Size by Application (2023-2028)
9.3.3 Latin America Nicotine Cessation Market Share by Application (2017-2028)
9.4 Latin America Nicotine Cessation Market Size by Country
9.4.1 Latin America Nicotine Cessation Market Size by Country (2017-2022)
9.4.2 Latin America Nicotine Cessation Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nicotine Cessation Market Size (2017-2028)
10.2 Middle East & Africa Nicotine Cessation Market Size by Type
10.2.1 Middle East & Africa Nicotine Cessation Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nicotine Cessation Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nicotine Cessation Market Share by Type (2017-2028)
10.3 Middle East & Africa Nicotine Cessation Market Size by Application
10.3.1 Middle East & Africa Nicotine Cessation Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nicotine Cessation Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nicotine Cessation Market Share by Application (2017-2028)
10.4 Middle East & Africa Nicotine Cessation Market Size by Country
10.4.1 Middle East & Africa Nicotine Cessation Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nicotine Cessation Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Nicotine Cessation Introduction
11.1.4 GSK Revenue in Nicotine Cessation Business (2017-2022)
11.1.5 GSK Recent Developments
11.2 Dr. Reddy’s Laboratories
11.2.1 Dr. Reddy’s Laboratories Company Details
11.2.2 Dr. Reddy’s Laboratories Business Overview
11.2.3 Dr. Reddy’s Laboratories Nicotine Cessation Introduction
11.2.4 Dr. Reddy’s Laboratories Revenue in Nicotine Cessation Business (2017-2022)
11.2.5 Dr. Reddy’s Laboratories Recent Developments
11.3 Cipla
11.3.1 Cipla Company Details
11.3.2 Cipla Business Overview
11.3.3 Cipla Nicotine Cessation Introduction
11.3.4 Cipla Revenue in Nicotine Cessation Business (2017-2022)
11.3.5 Cipla Recent Developments
11.4 Cigna
11.4.1 Cigna Company Details
11.4.2 Cigna Business Overview
11.4.3 Cigna Nicotine Cessation Introduction
11.4.4 Cigna Revenue in Nicotine Cessation Business (2017-2022)
11.4.5 Cigna Recent Developments
11.5 Chrono Therapeutics
11.5.1 Chrono Therapeutics Company Details
11.5.2 Chrono Therapeutics Business Overview
11.5.3 Chrono Therapeutics Nicotine Cessation Introduction
11.5.4 Chrono Therapeutics Revenue in Nicotine Cessation Business (2017-2022)
11.5.5 Chrono Therapeutics Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Nicotine Cessation Introduction
11.6.4 Pfizer Revenue in Nicotine Cessation Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Nicotine Cessation Introduction
11.7.4 Takeda Revenue in Nicotine Cessation Business (2017-2022)
11.7.5 Takeda Recent Developments
11.8 Achieve Life Sciences
11.8.1 Achieve Life Sciences Company Details
11.8.2 Achieve Life Sciences Business Overview
11.8.3 Achieve Life Sciences Nicotine Cessation Introduction
11.8.4 Achieve Life Sciences Revenue in Nicotine Cessation Business (2017-2022)
11.8.5 Achieve Life Sciences Recent Developments
11.9 McNeil AB
11.9.1 McNeil AB Company Details
11.9.2 McNeil AB Business Overview
11.9.3 McNeil AB Nicotine Cessation Introduction
11.9.4 McNeil AB Revenue in Nicotine Cessation Business (2017-2022)
11.9.5 McNeil AB Recent Developments
11.10 Ethismos
11.10.1 Ethismos Company Details
11.10.2 Ethismos Business Overview
11.10.3 Ethismos Nicotine Cessation Introduction
11.10.4 Ethismos Revenue in Nicotine Cessation Business (2017-2022)
11.10.5 Ethismos Recent Developments
11.11 NJOY
11.11.1 NJOY Company Details
11.11.2 NJOY Business Overview
11.11.3 NJOY Nicotine Cessation Introduction
11.11.4 NJOY Revenue in Nicotine Cessation Business (2017-2022)
11.11.5 NJOY Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Nicotine Cessation Introduction
11.12.4 Johnson & Johnson Revenue in Nicotine Cessation Business (2017-2022)
11.12.5 Johnson & Johnson Recent Developments
11.13 JUUL Labs
11.13.1 JUUL Labs Company Details
11.13.2 JUUL Labs Business Overview
11.13.3 JUUL Labs Nicotine Cessation Introduction
11.13.4 JUUL Labs Revenue in Nicotine Cessation Business (2017-2022)
11.13.5 JUUL Labs Recent Developments
11.14 Philip Morris International
11.14.1 Philip Morris International Company Details
11.14.2 Philip Morris International Business Overview
11.14.3 Philip Morris International Nicotine Cessation Introduction
11.14.4 Philip Morris International Revenue in Nicotine Cessation Business (2017-2022)
11.14.5 Philip Morris International Recent Developments
11.15 VMR Products
11.15.1 VMR Products Company Details
11.15.2 VMR Products Business Overview
11.15.3 VMR Products Nicotine Cessation Introduction
11.15.4 VMR Products Revenue in Nicotine Cessation Business (2017-2022)
11.15.5 VMR Products Recent Developments
11.16 Nicotek
11.16.1 Nicotek Company Details
11.16.2 Nicotek Business Overview
11.16.3 Nicotek Nicotine Cessation Introduction
11.16.4 Nicotek Revenue in Nicotine Cessation Business (2017-2022)
11.16.5 Nicotek Recent Developments
11.17 Lorillard
11.17.1 Lorillard Company Details
11.17.2 Lorillard Business Overview
11.17.3 Lorillard Nicotine Cessation Introduction
11.17.4 Lorillard Revenue in Nicotine Cessation Business (2017-2022)
11.17.5 Lorillard Recent Developments
11.18 Victory Electronic Cigarettes Corporation
11.18.1 Victory Electronic Cigarettes Corporation Company Details
11.18.2 Victory Electronic Cigarettes Corporation Business Overview
11.18.3 Victory Electronic Cigarettes Corporation Nicotine Cessation Introduction
11.18.4 Victory Electronic Cigarettes Corporation Revenue in Nicotine Cessation Business (2017-2022)
11.18.5 Victory Electronic Cigarettes Corporation Recent Developments
11.19 Revolymer
11.19.1 Revolymer Company Details
11.19.2 Revolymer Business Overview
11.19.3 Revolymer Nicotine Cessation Introduction
11.19.4 Revolymer Revenue in Nicotine Cessation Business (2017-2022)
11.19.5 Revolymer Recent Developments
11.20 Novartis International AG
11.20.1 Novartis International AG Company Details
11.20.2 Novartis International AG Business Overview
11.20.3 Novartis International AG Nicotine Cessation Introduction
11.20.4 Novartis International AG Revenue in Nicotine Cessation Business (2017-2022)
11.20.5 Novartis International AG Recent Developments
11.21 Imperial Brands Plc
11.21.1 Imperial Brands Plc Company Details
11.21.2 Imperial Brands Plc Business Overview
11.21.3 Imperial Brands Plc Nicotine Cessation Introduction
11.21.4 Imperial Brands Plc Revenue in Nicotine Cessation Business (2017-2022)
11.21.5 Imperial Brands Plc Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Nicotine Cessation Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chewing Gum
Table 3. Key Players of Patches
Table 4. Key Players of Sprays and Inhalers
Table 5. Key Players of Others
Table 6. Global Nicotine Cessation Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Nicotine Cessation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Nicotine Cessation Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Nicotine Cessation Market Share by Region (2017-2022)
Table 10. Global Nicotine Cessation Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Nicotine Cessation Market Share by Region (2023-2028)
Table 12. Nicotine Cessation Market Trends
Table 13. Nicotine Cessation Market Drivers
Table 14. Nicotine Cessation Market Challenges
Table 15. Nicotine Cessation Market Restraints
Table 16. Global Nicotine Cessation Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Nicotine Cessation Revenue Share by Players (2017-2022)
Table 18. Global Top Nicotine Cessation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotine Cessation as of 2021)
Table 19. Ranking of Global Top Nicotine Cessation Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Nicotine Cessation Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nicotine Cessation Product Solution and Service
Table 23. Date of Enter into Nicotine Cessation Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nicotine Cessation Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Nicotine Cessation Revenue Market Share by Type (2017-2022)
Table 27. Global Nicotine Cessation Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Nicotine Cessation Revenue Market Share by Type (2023-2028)
Table 29. Global Nicotine Cessation Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Nicotine Cessation Revenue Share by Application (2017-2022)
Table 31. Global Nicotine Cessation Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Nicotine Cessation Revenue Share by Application (2023-2028)
Table 33. North America Nicotine Cessation Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Nicotine Cessation Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Nicotine Cessation Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Nicotine Cessation Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Nicotine Cessation Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Nicotine Cessation Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Nicotine Cessation Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Nicotine Cessation Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Nicotine Cessation Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Nicotine Cessation Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Nicotine Cessation Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Nicotine Cessation Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Nicotine Cessation Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Nicotine Cessation Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Nicotine Cessation Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Nicotine Cessation Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Nicotine Cessation Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Nicotine Cessation Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Nicotine Cessation Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Nicotine Cessation Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Nicotine Cessation Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Nicotine Cessation Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Nicotine Cessation Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Nicotine Cessation Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Nicotine Cessation Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Nicotine Cessation Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Nicotine Cessation Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Nicotine Cessation Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Nicotine Cessation Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Nicotine Cessation Market Size by Country (2023-2028) & (US$ Million)
Table 63. GSK Company Details
Table 64. GSK Business Overview
Table 65. GSK Nicotine Cessation Product
Table 66. GSK Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 67. GSK Recent Developments
Table 68. Dr. Reddy's Laboratories Company Details
Table 69. Dr. Reddy's Laboratories Business Overview
Table 70. Dr. Reddy's Laboratories Nicotine Cessation Product
Table 71. Dr. Reddy's Laboratories Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 72. Dr. Reddy's Laboratories Recent Developments
Table 73. Cipla Company Details
Table 74. Cipla Business Overview
Table 75. Cipla Nicotine Cessation Product
Table 76. Cipla Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 77. Cipla Recent Developments
Table 78. Cigna Company Details
Table 79. Cigna Business Overview
Table 80. Cigna Nicotine Cessation Product
Table 81. Cigna Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 82. Cigna Recent Developments
Table 83. Chrono Therapeutics Company Details
Table 84. Chrono Therapeutics Business Overview
Table 85. Chrono Therapeutics Nicotine Cessation Product
Table 86. Chrono Therapeutics Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 87. Chrono Therapeutics Recent Developments
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Nicotine Cessation Product
Table 91. Pfizer Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 92. Pfizer Recent Developments
Table 93. Takeda Company Details
Table 94. Takeda Business Overview
Table 95. Takeda Nicotine Cessation Product
Table 96. Takeda Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 97. Takeda Recent Developments
Table 98. Achieve Life Sciences Company Details
Table 99. Achieve Life Sciences Business Overview
Table 100. Achieve Life Sciences Nicotine Cessation Product
Table 101. Achieve Life Sciences Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 102. Achieve Life Sciences Recent Developments
Table 103. McNeil AB Company Details
Table 104. McNeil AB Business Overview
Table 105. McNeil AB Nicotine Cessation Product
Table 106. McNeil AB Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 107. McNeil AB Recent Developments
Table 108. Ethismos Company Details
Table 109. Ethismos Business Overview
Table 110. Ethismos Nicotine Cessation Product
Table 111. Ethismos Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 112. Ethismos Recent Developments
Table 113. NJOY Company Details
Table 114. NJOY Business Overview
Table 115. NJOY Nicotine Cessation Product
Table 116. NJOY Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 117. NJOY Recent Developments
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Business Overview
Table 120. Johnson & Johnson Nicotine Cessation Product
Table 121. Johnson & Johnson Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 122. Johnson & Johnson Recent Developments
Table 123. JUUL Labs Company Details
Table 124. JUUL Labs Business Overview
Table 125. JUUL Labs Nicotine Cessation Product
Table 126. JUUL Labs Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 127. JUUL Labs Recent Developments
Table 128. Philip Morris International Company Details
Table 129. Philip Morris International Business Overview
Table 130. Philip Morris International Nicotine Cessation Product
Table 131. Philip Morris International Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 132. Philip Morris International Recent Developments
Table 133. VMR Products Company Details
Table 134. VMR Products Business Overview
Table 135. VMR Products Nicotine Cessation Product
Table 136. VMR Products Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 137. VMR Products Recent Developments
Table 138. Nicotek Company Details
Table 139. Nicotek Business Overview
Table 140. Nicotek Nicotine Cessation Product
Table 141. Nicotek Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 142. Nicotek Recent Developments
Table 143. Lorillard Company Details
Table 144. Lorillard Business Overview
Table 145. Lorillard Nicotine Cessation Product
Table 146. Lorillard Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 147. Lorillard Recent Developments
Table 148. Victory Electronic Cigarettes Corporation Company Details
Table 149. Victory Electronic Cigarettes Corporation Business Overview
Table 150. Victory Electronic Cigarettes Corporation Nicotine Cessation Product
Table 151. Victory Electronic Cigarettes Corporation Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 152. Victory Electronic Cigarettes Corporation Recent Developments
Table 153. Revolymer Company Details
Table 154. Revolymer Business Overview
Table 155. Revolymer Nicotine Cessation Product
Table 156. Revolymer Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 157. Revolymer Recent Developments
Table 158. Novartis International AG Company Details
Table 159. Novartis International AG Business Overview
Table 160. Novartis International AG Nicotine Cessation Product
Table 161. Novartis International AG Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 162. Novartis International AG Recent Developments
Table 163. Imperial Brands Plc Company Details
Table 164. Imperial Brands Plc Business Overview
Table 165. Imperial Brands Plc Nicotine Cessation Product
Table 166. Imperial Brands Plc Revenue in Nicotine Cessation Business (2017-2022) & (US$ Million)
Table 167. Imperial Brands Plc Recent Developments
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nicotine Cessation Market Share by Type: 2021 VS 2028
Figure 2. Chewing Gum Features
Figure 3. Patches Features
Figure 4. Sprays and Inhalers Features
Figure 5. Others Features
Figure 6. Global Nicotine Cessation Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Nicotine Cessation Report Years Considered
Figure 12. Global Nicotine Cessation Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Nicotine Cessation Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Nicotine Cessation Market Share by Region: 2021 VS 2028
Figure 15. Global Nicotine Cessation Market Share by Players in 2021
Figure 16. Global Top Nicotine Cessation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotine Cessation as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Nicotine Cessation Revenue in 2021
Figure 18. North America Nicotine Cessation Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Nicotine Cessation Market Size Market Share by Type (2017-2028)
Figure 20. North America Nicotine Cessation Market Size Market Share by Application (2017-2028)
Figure 21. North America Nicotine Cessation Market Size Share by Country (2017-2028)
Figure 22. United States Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Nicotine Cessation Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Nicotine Cessation Market Size Market Share by Type (2017-2028)
Figure 26. Europe Nicotine Cessation Market Size Market Share by Application (2017-2028)
Figure 27. Europe Nicotine Cessation Market Size Share by Country (2017-2028)
Figure 28. Germany Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Nicotine Cessation Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Nicotine Cessation Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Nicotine Cessation Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Nicotine Cessation Market Size Share by Region (2017-2028)
Figure 38. China Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Nicotine Cessation Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Nicotine Cessation Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Nicotine Cessation Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Nicotine Cessation Market Size Share by Country (2017-2028)
Figure 48. Mexico Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Nicotine Cessation Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Nicotine Cessation Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Nicotine Cessation Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Nicotine Cessation Market Size Share by Country (2017-2028)
Figure 54. Turkey Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Nicotine Cessation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. GSK Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 58. Dr. Reddy's Laboratories Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 59. Cipla Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 60. Cigna Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 61. Chrono Therapeutics Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 62. Pfizer Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 63. Takeda Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 64. Achieve Life Sciences Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 65. McNeil AB Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 66. Ethismos Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 67. NJOY Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 68. Johnson & Johnson Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 69. JUUL Labs Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 70. Philip Morris International Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 71. VMR Products Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 72. Nicotek Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 73. Lorillard Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 74. Victory Electronic Cigarettes Corporation Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 75. Revolymer Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 76. Novartis International AG Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 77. Imperial Brands Plc Revenue Growth Rate in Nicotine Cessation Business (2017-2022)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed